Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Европейски съюз - български - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - грипен вирус повърхностните антигени (хемаглутинин и невраминидазния) на щам a/Виетнам/1194/2004 (Н5n1) - influenza, human; immunization; disease outbreaks - Ваксини - Активна имунизация срещу подтип h5n1 на вируса на грипа А. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Европейски съюз - български - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - Ваксини - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Zoonotic Influenza Vaccine Seqirus Европейски съюз - български - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - Ваксини - active immunisation against h5 subtype of influenza a virus.

Spikevax (previously COVID-19 Vaccine Moderna) Европейски съюз - български - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Ваксини - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Vancocin CP  lg powder for solution for infusion България - български - Изпълнителна агенция по лекарствата

vancocin cp  lg powder for solution for infusion

Чайкафарма Висококачествените лекарства АД - Ванкомицин - lg powder for solution for infusion

Vancomycin-Mip 500 mg powder for solution for infusion България - български - Изпълнителна агенция по лекарствата

vancomycin-mip 500 mg powder for solution for infusion

mip pharma gmbh - Ванкомицин - 500 mg powder for solution for infusion

Vancomycin-Mip 1000 mg powder for solution for infusion България - български - Изпълнителна агенция по лекарствата

vancomycin-mip 1000 mg powder for solution for infusion

mip pharma gmbh - Ванкомицин - 1000 mg powder for solution for infusion

Vancomycin Hospira 500 mg powder for concetrate for solution for infusion България - български - Изпълнителна агенция по лекарствата

vancomycin hospira 500 mg powder for concetrate for solution for infusion

hospira uk ltd. - Ванкомицин - 500 mg powder for concetrate for solution for infusion

Vancomycin Hospira 1000 mg powder for concentrate for solution for infusion България - български - Изпълнителна агенция по лекарствата

vancomycin hospira 1000 mg powder for concentrate for solution for infusion

hospira uk ltd. - Ванкомицин - 1000 mg powder for concentrate for solution for infusion

Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) Европейски съюз - български - EMA (European Medicines Agency)

pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)

astrazeneca ab - ресусортен грипен вирус (жив атенюиран) на следния щам: щам a / vietnam / 1203/2004 (h5n1) - Грип, Човек - Ваксини - Профилактика на грип при официално обявена пандемична ситуация при деца и юноши на възраст от 12 месеца до 18 години. Ваксина срещу пандемичен грип h5n1 АстраЗенека трябва да се използва в съответствие с официалните насоки.